Skip to main content

Table 3 Demographic distribution of MDR isolates and ESBL producers

From: Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal

Characters

Growth positive, N (%)

MDR, N (%)

p value

ESBL producers, N (%)

p value

Sex

 Male (n = 424)

48 (11.3)

46 (95.8)

0.146

7 (14.6)

0.436

 Female (n = 346)

44 (12.7)

38 (86.4)

9 (20.5)

Age group

 < 10 (n = 123)

12 (9.8)

12 (100)

0.77

2 (16.7)

0.596

 11–20 (n = 90)

4 (4.4)

3 (75)

0 (0.0)

 21–30 (n = 84)

9 (10.7)

8 (88.9)

1 (11.1)

 31–40 (n = 105)

21 (20.0)

20 (95.2)

5 (23.8)

 41–50 (n = 71)

8 (11.3)

7 (87.5)

3 (37.5)

 51–60 (101)

11 (10.9)

10 (90.9)

2 (18.2)

 > 60 (n = 196)

27 (13.8)

24 (88.9)

3 (11.1)

Department

 Inpatient (n = 503)

33 (6.6)

27 (81.8)

0.016

7 (21.2)

0.693

 Outpatient (n = 197)

59 (29.9)

57 (96.6)

9 (15.3)

Sample

 Urine (n = 250)

52 (20.8)

47 (90.4)

0.195

12 (23.1)

0.714

 Sputum (n = 185)

18 (9.7)

18 (100)

3 (16.7)

 Pus (n = 115)

6 (5.2)

4 (66.6)

0 (0.0)

 Blood (n = 166)

8 (4.8)

8 (100)

1 (12.5)

 Wound (n = 49)

5 (10.2)

4 (80)

0 (0.0)

 Tissue (n = 5)

3 (60.0)

2 (66.6)

0 (0.0)

n = 770

n = 92 (11.9)

n = 84 (91.3)

 

n = 16 (17.4)

Â